STAT3 and ovarian carcinoma: The JAK/STAT3 pathway is often upregulated in ovarian cancer, leading to an immunosuppressive tumor microenvironment that can promote tumor cell growth and survival, inhibits apoptosis, and enhances angiogenesis and immune evasion [74, 75].